blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0701818

EP0701818 - Therapeutic methods using catalytic antibodies [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  04.06.2004
Database last updated on 03.09.2024
Most recent event   Tooltip04.06.2004No opposition filed within time limitpublished on 21.07.2004  [2004/30]
Applicant(s)For all designated states
IGEN International, Inc.
16020 Industrial Drive
Gaithersburg, MD 20877 / US
[2003/31]
Former [1999/04]For all designated states
Igen International, Inc.
16020 Industrial Drive
Gaithersburg, MD 20877 / US
Former [1996/12]For all designated states
IGEN, INC.
1530 East Jefferson Street
Rockville, MD 20852 / US
Inventor(s)01 / Powell, Michael J.
5 War Admiral Court
Gaithersburg, Maryland 20852 / US
02 / Massey, Richard J.
5 Valerian Court
Rockville, Maryland 20852 / US
03 / Rees, Anthony R.
1530 East Jefferson Street
Rockville, Maryland 20852 / US
[1996/12]
Representative(s)Schlich, George William, et al
Mathys & Squire LLP
120 Holborn
London
EC1N 2SQ / GB
[N/P]
Former [1996/12]Schlich, George William, et al
Mathys & Squire 100 Grays Inn Road
London WC1X 8AL / GB
Application number, filing date95111577.304.05.1989
[1996/12]
Priority number, dateUS1988019027104.05.1988         Original published format: US 190271
[1996/12]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0701818
Date:20.03.1996
Language:EN
[1996/12]
Type: A3 Search report 
No.:EP0701818
Date:04.06.1997
[1997/23]
Type: B1 Patent specification 
No.:EP0701818
Date:30.07.2003
Language:EN
[2003/31]
Search report(s)(Supplementary) European search report - dispatched on:EP18.04.1997
ClassificationIPC:A61K39/395, // C12N9/00
[1996/12]
CPC:
C07D207/404 (EP); A61P31/00 (EP); A61P31/04 (EP);
A61P31/12 (EP); A61P31/18 (EP); A61P35/00 (EP);
A61P37/00 (EP); A61P37/08 (EP); A61P43/00 (EP);
A61P9/12 (EP); C07C229/46 (EP); C07C229/48 (EP);
C07C235/74 (EP); C07C271/24 (EP); C07C311/06 (EP);
C07C317/44 (EP); C07D205/085 (EP); C07F9/2458 (EP);
C07F9/301 (EP); C07F9/3211 (EP); C07F9/4006 (EP);
C07F9/5537 (EP); C07K16/00 (EP); C07K16/1063 (EP);
C12N9/0002 (EP); C12Q1/25 (EP); G01N33/531 (EP);
G01N33/577 (EP); C07C2601/04 (EP); C07C2602/42 (EP);
G01N2333/16 (EP); G01N2333/96472 (EP) (-)
Designated contracting statesAT,   BE,   CH,   DE,   FR,   GB,   IT,   LI,   LU,   NL,   SE [1996/12]
TitleGerman:Heilungsverfahren unter Verwendung katalytischer Antikörper[1996/12]
English:Therapeutic methods using catalytic antibodies[1996/12]
French:Procédés thérapeutiques utilisant des anticorps catalytiques[1996/12]
Examination procedure24.07.1995Examination requested  [1996/12]
15.12.2000Despatch of a communication from the examining division (Time limit: M08)
27.08.2001Reply to a communication from the examining division
26.04.2002Despatch of a communication from the examining division (Time limit: M04)
30.08.2002Reply to a communication from the examining division
10.10.2002Communication of intention to grant the patent
02.04.2003Fee for grant paid
02.04.2003Fee for publishing/printing paid
Parent application(s)   TooltipEP89906520.5  / EP0436545
Opposition(s)04.05.2004No opposition filed within time limit [2004/30]
Fees paidRenewal fee
24.07.1995Renewal fee patent year 03
24.07.1995Renewal fee patent year 04
24.07.1995Renewal fee patent year 05
24.07.1995Renewal fee patent year 06
24.07.1995Renewal fee patent year 07
22.04.1996Renewal fee patent year 08
23.06.1997Renewal fee patent year 09
26.05.1998Renewal fee patent year 10
23.04.1999Renewal fee patent year 11
25.04.2000Renewal fee patent year 12
20.04.2001Renewal fee patent year 13
21.05.2002Renewal fee patent year 14
26.05.2003Renewal fee patent year 15
Penalty fee
Additional fee for renewal fee
01.06.199709   M06   Fee paid on   23.06.1997
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO8502414  (IGEN INC [US]) [A] 1-16* the whole document *;
 [X]EP0251093  (KOLLMORGEN CORP [US]) [X] 1-14,16 * page 10; tables 11,12 * * page 13 - page 14; tables 18-20 * * page 15 - page 16; tables 22-24 * * page 23 * * claims 1-24 *;
 [X]EP0260939  (SCRIPPS CLINIC RES [US]) [X] 1-14,16 * page 9 * * claims 1-7 *;
 [XP]EP0305870  (KOLLMORGEN CORP [US]) [XP] 1-5,10 * column W *;
 [E]WO9013661  (IGEN INC [US]) [E] 1,2,5 * the whole document *;
 [X]  - VAN BRUNT J., "Antibodies find a new role-As enzymes", BIOTECHNOLOGY, NEW YORK US, vol. 5, no. 8, page 767, XP002028355 [X] 1-14,16 * the whole document *

DOI:   http://dx.doi.org/10.1038/nbt0887-767
 [X]  - LETHUILLIER A., "Les abzymes: des anticorps convertis en enzymes", RECHERCHE, LA, PARIS FR, vol. 18, no. 187, pages 516 - 517, XP002028356 [X] 1-14,16 * the whole document *
 [X]  - LERNER A.L. ET AL, "catalytic antibodies", SCIENTIFIC AMERICAN, NEW YORK US, vol. 258, no. 3, pages 42 - 50, XP002028357 [X] 1-14,16 * the whole document *
by applicantUS4196265
 US4659567
 EP0251093
    - SOCHER ET AL., PROC. NATL. ACAD. SCI. USA, (1987), vol. 84, pages 8829 - 8833
    - LASK ET AL., CELL, (1987), vol. 50, pages 975 - 985
    - KOERNER, NIEMAN, J. CHROMATOGRAPHY, (1988), vol. 449, pages 216 - 228
    - GISH ET AL., J. MED. CHEM., (1971), vol. 14, pages 1159 - 1162
    - A.D. NAPPER ET AL., "A Stereospecific Cyclization Catalyzed by an Antibody", SCIENCE, (1987), vol. 237, doi:doi:10.1126/science.3616626, pages 1041 - 1043, XP000617227

DOI:   http://dx.doi.org/10.1126/science.3616626
    - A. TRAMONTANO ET AL., "Chemical Reactivity at an Antibody Binding Site Elicited By Mechanistic Design of a Synthetic Antigen", PROC. NATL. ACAD. SCI. USA, (1986), vol. 83, pages 6736 - 6740
    - H. WHITE, W.P. JENCKS, J. BIOL. CHEM., (1976), vol. 252, page 1688
    - H. WHITE ET AL., J. BIOL. CHEM., (1976), vol. 252, page 1700
    - H.M. GEYSEN ET AL., J. IMMUNOLOGICAL METHODS, (1987), vol. 102, pages 259 - 274
    - H.M. GEYSEN ET AL., PROC. NATL. ACAD. SCI. USA, (1985), vol. 82, pages 178 - 182
    - J.A. BERZOFSKY, SCIENCE, (1985), vol. 229, pages 932 - 940
    - T.P. HOPP, K.R. WOODS, PROC. NATL. ACAD. SCI. USA, (1981), vol. 78, pages 3824 - 3828
    - J. NOVOTNY ET AL., PROC. NATL. ACAD. SCI. USA, (1986), vol. 226
    - H.M. GEYSEN ET AL., SCIENCE, (1978), vol. 235, page 1184
    - A. FERSHT, Enzyme Structure and Mechanism, NEW YORK, W.H. FREEMAN AND CO., (1985), pages 433 - 436
    - J. BLUNDELL ET AL., NATURE, (1983), vol. 304, pages 273 - 275
    - P. CORVOL ET AL., J. BIOL. CHEM., (1987), vol. 262, no. 6, pages 2913 - 2918
    - E. ATHERTON, R.J. SHEPPARD, J. CHEM. SOC. COMMUN., (1981), pages 1151 - 1152
    - M. WILCHEK, S. BANNIGER, METHODS ENZYMOL., (1980), vol. 70, pages 151 - 159
    - J. MENARD, K.J. CATT, ENDOCRINOLOGY, (1972), vol. 90, pages 422 - 430
    - C.B. PERT ET AL., PROC. NATL. ACAD. SCI. USA, (1986), vol. 83, pages 9254 - 9258
    - M.R. PINCUS ET AL., BIOCHEM. BIOPHYS. RES. COMMUN., (1987), vol. 143(A), pages 248 - 251
    - D.M. KATZ ET AL., BIOCHEMISTRY, (1979), vol. 18, pages 690 - 697
    - ANDERSON ET AL., CRU, (1977), vol. 10, page 27
    - M.D. SCHAFF ET AL., CELL, (1976), vol. 8, page 405
    - C. MILSTEIN ET AL., NATURE, (1977), vol. 266, page 550
    - J.W. LITTLEFIELD, EXPT'L. CELL RES., (1966), vol. 41, page 190
    - D. HO, J. VIROL., (1987), vol. 61, page 2024
    - B.D. WALKER ET AL., PROC. NATL. ACAD. SCI. USA, (1987), vol. 84, page 8120
 US19880190271
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.